Mirum Pharmaceuticals, Inc. 4.0% 01-MAY-2029Mirum Pharmaceuticals, Inc. 4.0% 01-MAY-2029Mirum Pharmaceuticals, Inc. 4.0% 01-MAY-2029

Mirum Pharmaceuticals, Inc. 4.0% 01-MAY-2029

No trades
See on Supercharts

MIRM5806400 analysis



Key facts


Issue date
Apr 30, 2024
Maturity date
May 1, 2029
Outstanding amount
‪316.25 M‬USD
Face value
1,000.00USD
Minimum denomination
1,000.00USD
Coupon
4.00% (Fixed)
Yield to maturity
−5.83%
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.